Search research articles
Contact Us
Filters
Showing results (331-340 of 368) with videos related to
Page
of 37
Sort By:
Blood
|
February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
Saad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
JAMA Oncology
|
April 26, 2019
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis
Yucai Wang, Shouhao Zhou, Fang Yang, et al.
British Journal of Haematology
|
May 4, 2017
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma
Narendranath Epperla, Anthony Q Pham, Brian L Burnette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2013
Bowel perforation in intestinal lymphoma: incidence and clinical features
R Vaidya, T M Habermann, J H Donohue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial
J Guo, R D Carvajal, R Dummer, et al.
The Oncologist
|
November 19, 2024
Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanoma
Jeffrey Weber, Waqas Haque, Svetomir N Markovic, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2024
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma
Ugur Sener, Mason Webb, William G Breen, et al.
JCO Precision Oncology
|
October 26, 2023
Plasma Methylated DNA Markers for Melanoma Surveillance
Calise K Berger, William R Taylor, Douglas W Mahoney, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2017
Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
Lisa Zimmer, Susmitha Apuri, Zeynep Eroglu, et al.
American Journal of Hematology
|
September 18, 2014
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma
Thomas E Witzig, Matthew J Maurer, Thomas M Habermann, et al.
Page
of 37
Search research articles
Search
Showing results (331-340 of 368) with videos related to
Sort By:
Page
of 37
Blood
|
February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
Saad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
JAMA Oncology
|
April 26, 2019
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis
Yucai Wang, Shouhao Zhou, Fang Yang, et al.
British Journal of Haematology
|
May 4, 2017
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma
Narendranath Epperla, Anthony Q Pham, Brian L Burnette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2013
Bowel perforation in intestinal lymphoma: incidence and clinical features
R Vaidya, T M Habermann, J H Donohue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial
J Guo, R D Carvajal, R Dummer, et al.
The Oncologist
|
November 19, 2024
Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanoma
Jeffrey Weber, Waqas Haque, Svetomir N Markovic, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2024
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma
Ugur Sener, Mason Webb, William G Breen, et al.
JCO Precision Oncology
|
October 26, 2023
Plasma Methylated DNA Markers for Melanoma Surveillance
Calise K Berger, William R Taylor, Douglas W Mahoney, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2017
Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
Lisa Zimmer, Susmitha Apuri, Zeynep Eroglu, et al.
American Journal of Hematology
|
September 18, 2014
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma
Thomas E Witzig, Matthew J Maurer, Thomas M Habermann, et al.
Page
of 37